Press Releases

XORTX Announces Update for Discussion with the FDA

XORTX Commences Gout Program NDA Discussions with the FDA

XORTX to Present at Microcap Conference

XORTX Announces Change of Auditor

XORTX Adds Late Stage Gout Program to Pipeline

XORTX Strengthens Executive Team

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement